Revlimid.com

Visit revlimid.com
  • 739.9K

    Global Rank

  • 801

    Daily Visitors

  • 1 week ago

    Last scanned

  • 20 years

    Domain Age

Revlimid.com

Visit revlimid.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

REVLIMID® (lenalidomide) - Official Patient Website

Learn more about REVLIMID® (lenalidomide). Please see Indication and Important Safety Information, including Boxed WARNINGS.

Revlimid.com thumbnail
Revlimid.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Incapsula Inc, which reserves the following IP addresses for revlimid.com: 45.60.150.161. Moreover, DNS used with this website include ns-1413.awsdns-48.org, ns-1716.awsdns-22.co.uk, ns-240.awsdns-30.com, ns-650.awsdns-17.net. Subnet identifier ranges from 45.60.0.0 to 45.60.255.255. Classless Inter-Domain Routing (CIDR) is 45.60.0.0/16. ARIN net type is Direct Allocation.

  • 739.9K

    Global Rank

  • 801

    Daily Visitors

  • 1 week ago

    Last scanned

  • 20 years

    Domain Age

Trustworthy

Network

ADDRESSING DETAILS

  • Hosting Company

    Incapsula Inc

  • IPs

    45.60.150.161

  • DNS

    ns-1413.awsdns-48.org

    ns-1716.awsdns-22.co.uk

    ns-240.awsdns-30.com

    ns-650.awsdns-17.net

Whois

OWNERSHIP

Domain & Keywords

The registrar of revlimid.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-08-19. According to open source data, you can reach the owner at dns.admin@BMS.COM but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • treatment
  • newly diagnosed
  • Indications
  • mantle cell lymphoma
  • celgene
  • revlimid cost
  • prescribing information
  • lenalidomide
  • deletion 5q myelodysplastic syndromes
  • revlamid

Websites similar to revlimid.com

Revlimid.com friends